Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Body Radiotherapy for Bone Only Oligometastatic Breast Cancer: A Prospective Study

NCT04424732 is registered in ClinicalTrials.gov with King Hussein Cancer Center as lead sponsor.

NCT NCT04424732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04424732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Body Radiotherapy for Bone Only Oligometastatic Breast Cancer: A Prospective Study
Lead sponsor
King Hussein Cancer Center
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2020
Completion date
June 1, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm malignant female